SCHEMBL2157385

SCHEMBL2157385

Cc1ccccc1OCCN1CCN(C(=O)CCCc2ccc3c(c2)OCCO3)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
HTT P42858 2/20 0.51
LMNA P02545 2/20 0.51
USP2 O75604 1/20 0.51
KCNA5 P22460 2/20 0.48
TRPV1 Q8NER1 1/20 0.47
KDM4E B2RXH2 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
MAPT P10636 2/20 0.47
AR P10275 1/20 0.45
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
GLA P06280 1/20 0.44
HPGD P15428 1/20 0.44
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2158174 0.83 TRPV1 (0.48) MEN1KMT2AHTTLMNAUSP2
SCHEMBL2157454 0.74 SIGMAR1 (0.50) MEN1KMT2AKDM4EADRA1DADRA1A
SCHEMBL2158203 0.74 CHRM5 (0.48) MEN1KMT2AHTTLMNAUSP2
SCHEMBL2158498 0.72 SIGMAR1 (0.58) KCNA5KDM4ENPC1RAB9AADRA1D
SCHEMBL2157438 0.70 DRD3 (0.46) MEN1KMT2AKDM4EADRA1DADRA1A
SCHEMBL24893035 0.70 ALDH1A1 (0.72) MEN1KMT2ALMNATRPV1KDM4E
SCHEMBL2158468 0.70 ABCB1 (0.44) MEN1KMT2AADRA1DADRA1AADRA1B
SCHEMBL2572413 0.70 ADRA1D (0.54) MEN1KMT2AKDM4EMAPTALDH1A1
SCHEMBL7032807 0.69 DRD3 (0.53) KMT2ALMNAKCNA5MAPTALDH1A1
SCHEMBL3821384 0.69 TRPV1 (0.51) MEN1KMT2AHTTLMNATRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183374-B2 Piperidine and piperazine derivatives M'S SCIENCE CORPORATION (JP) 2012-05-22 US disclosed
EP-2340835-A1 Piperidine and piperazine derivatives M's Science Corporation (JP) 2011-07-06 EP disclosed
EP-1976525-B1 PIPERIDINE AND PIPERAZINE DERIVATIVES MS SCIENCE CORP (JP) 2010-11-03 EP disclosed
US-20100137334-A1 Piperidine and Piperazine Derivatives SUN CONNIE L 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137334-A1 Piperidine and Piperazine Derivatives SIGMAR1, OPRM1, OPRD1 MEN1 2035/4885KMT2A 1809/4885HTT 2654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.